Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurol.

Sec. Stroke

This article is part of the Research TopicStroke Research in the Elderly: Addressing Ageism and PrognosticationView all 13 articles

Relationship between all-cause mortality and triglyceride-glucose-body mass index in elderly patients with intravenous thrombolysis for acute ischemic stroke: a retrospective cohort study

Provisionally accepted
  • 1Fuyang Normal University, Fuyang, China
  • 2The Affiliated Fuyang People’s Hospital of Anhui Medical University, Fuyang, China
  • 3Intensive Care Unit,The Second Hospital Affiliated to Fuyang Normal University, Fuyang, China, Fuyang, China

The final, formatted version of the article will be published soon.

Background: Triglyceride-glucose-body mass index (TyG-BMI) has been shown to be a reliable surrogate for insulin resistance (IR), but the relationship between TyG-BMI and acute ischemic stroke (AIS) is unclear. In this study, we investigated the relationship between TyG-BMI and long-term all-cause mortality in elderly patients with intravenous thrombolysis for AIS. Methods: We enrolled 452 elderly patients with acute ischemic stroke treated with intravenous thrombolysis with alteplase and divided them into four groups according to TyG-BMI quartiles, and the endpoint event of the study was all-cause death from AIS. The Kaplan-Meier (K-M) curve method was used to compare the outcomes among the groups, while multivariate Cox proportional risk regression models and restricted cubic spline (RCS) were utilized to explore the association between TyG-BMI and these outcomes. In addition, subgroup analyses were performed. Results: A total of 452 elderly patients with intravenous thrombolysis for AIS were included, with a median age of 73.0 years, an interquartile range of 68.0-78.0 years, 58.4% males, a mean TyG-BMI of 205.54 ± 38.51. The follow-up period was more than six years, after which 75 (16.6%) patients died. K-M curve analysis demonstrated that patients with lower TyG-BMI levels had a higher risk of long-term all-cause mortality from AIS. When TyG-BMI was classified according to quartiles, Cox proportional risk regression analysis confirmed that both the Q1 group [HR, 3.482; 95% CI: 1.560-7.774; P=0.002], Q3 group [HR,2.819 ; 95% CI: 1.196-6.640; P=0.018] and the Q4 group [HR, 2.928; 95% CI: 1.259-6.806; P=0.013] were associated with higher all-cause mortality rates, using the quartile with the lowest mortality as the reference. In addition, restricted cubic spline curves revealed a nonlinear relationship between TyG-BMI and long-term all-cause mortality (nonlinear p-value = 0.048). Conclusion: In this study, we found a U-shaped correlation between TyG-BMI and long-term all-cause mortality in elderly patients with AIS undergoing intravenous thrombolysis. TyG-BMI can be used as a predictor of all-cause mortality in this group of patients.

Keywords: Acute ischemic stroke, All-cause mortality, Triglyceride-glucose-body mass index, thrombolysis, Insulin Resistance

Received: 20 Aug 2025; Accepted: 19 Nov 2025.

Copyright: © 2025 Cheng, Zhai and Xie. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Zhubiao Xie, xzb202508@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.